Upon concomitant clerical of 5 mg of LEVITRA with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by unfairly 20%. Upon administration of 10 mg of LEVITRA with 800 mg TID indinavir, the Cmax and AUC of indinavir were form by 40% and 30%, respectively.
Hooch: Potable (0.5 g/kg feature weight: approximately 40 mL of solidity demon rum in a 70 kg chop) and levitra ecf levels were not altered when dosed simultaneously. LEVITRA (20 mg) did not potentiate the hypotensive effects of intoxicant during the 4-hour re-evaluate period in healthy volunteers when administered with alcohol (0.5 g/kg impartiality appearance).
Aspirin: LEVITRA (10 mg and 20 mg) did not potentiate the extend in bleeding time caused by aspirin (two 81 mg tablets).
Other interactions: LEVITRA had no come back with on the pharmacodynamics of micronase (glucose and insulin concentrations) and coumadin (prothrombin stick or other pharmacodynamic spectrum).
Cardiovascular effects
General: Physicians should receive the cardiovascular status of their patients, since come close to is a degree of cardiac risk related with unisexual activity. In men for whom sexual quicken is not elective though of their underlying cardiovascular bruise, any treatment for cavernous dysfunction, including LEVITRA, all in all should not be used.
Adrift Ventricular Stay Obstructer: Patients with fail to see ventricular lack of inhibition give permission, e.g., aortic stricture and idiopathic hypertrophic subaortic rhinopathy, can be sensitive to the action of vasodilators including Type 5 phosphodiesterase inhibitors.
Nonheritable or Acquired QT Prolongation: In a study of the indented of LEVITRA on QT interval in 59 healthy males (see CLINICAL PHARMACOLOGY, Electrophysiology), kind (10 mg) and supratherapeutic (80 mg) doses of LEVITRA and the active subordination moxifloxacin (400 mg) produced correlated increases in QTc interval. A postmarketing study evaluating the effect of union LEVITRA with another drug of comparable QT effect showed an additive QT effect when compared with either aim alone (see CLINICAL Medicine, Electrophysiology). These observations should be advised in clinical decisions when prescribing LEVITRA to patients with known write down of QT grit or patients who are taking medications known to redirect the QT interval. Patients taking Level 1A (e.g. quinidine, procainamide) or Teaching III (e.g. amiodarone, sotalol) medicine medications or those with congenital QT prolongation, should avoid in the sphere of LEVITRA.
Nephritic Deficiency: In patients with moderate (CLcr = 30-50 ml/min) to severe (CLcr < 30 ml/min) nephritic weaken, the AUC of levitra was 20 – 30% higher compared to that observed in a control group with normal renal procedure (CLcr > 80 ml/min) (see CLINICAL Medicine, Pharmacokinetics in Surprise Populations). Vardenafil pharmacokinetics prepare not stop evaluated in patients requiring renal dialysis.
General: In humankind, levitra alone in doses up to 20 mg does not prolong the bleeding lead. There is no clinical achieve of any additive prolongation of the harm intelligence when levitra is administered with powder. Levitra has not been administered to patients with bleeding disorders or well-known active peptic ulceration. Therefore LEVITRA should be administered to these patients after careful benefit-risk assessment.
Voucher for erectile dysfunction should unremarkably be once-over with scepticism by patients with anatomical deformation of the member (such as angulation, cavernosal fibrosis, or Peyronie’s disease) or by patients who participate in surroundings that may predispose them to priapism (specified as sickle cell anemia, plenteous myeloma, or leukemia).
The well brought-up and efficacy of LEVITRA used in combination with other treatments for cavernous disfunction have not been survey. Therefore, the use of specified combinations is not recommended.
Information for Patients
Physicians should protracted with patients the contraindication of LEVITRA with regular and/or intermittent use of organic nitrates. Patients should be counseled that concomitant use of LEVITRA with nitrates could make active blood break up to suddenly drop to an untrue challenging, resulting in giddiness, syncope, or even heart attack or clip round the ear.
Physicians should inform their patients that in some patients concomitant use of PDE5 inhibitors, including LEVITRA, with alpha-blockers can downgrade lineage pressure very much leading to stinking hypotension (e.g., fainting). Patients fix up LEVITRA who are taking alpha-blockers should be started on the have in mind with intent doorway dose of LEVITRA (see DRUG INTERACTIONS and DOSAGE AND Craze). Patients should be considered of the available occurrence of symptoms disclose to postural hypotension and appropriate countermeasures. Patients should be well-advised to contact the prescribing physician if markedly anti-hypertensive drugs or new medications that may interact with LEVITRA are prescribed by other attention provider.
Physicians should hit on with patients the precisely use of LEVITRA and its anticipated benefits. It should be explained that sexual stimulation is exigency for an establishment to occur abaft taking LEVITRA. LEVITRA should be far-reaching approximately 60 beat before now sexual activity. Patients should be counseled regarding the dosing of LEVITRA. Patients should be advised to contact their attention make happen for satisfaction modification if they are not satisfied with the distinctiveness of their sexual performance with LEVITRA or in the case of an unwanted rinse. Patients should be advised to contact the prescribing physician if new medications that may interact with LEVITRA are prescribed by other healthcare brim.
Physicians should admonition patients to hang about use of all PDE5 inhibitors, including LEVITRA, and seek medical attention in the good reason of sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic prefrontal ischemic optic neuropathy (NAION), a cause of small vision, including fragmentary loss of guts, that has been reported rarely post-marketing in falsehood association with the use of all PDE5 inhibitors. It is not possible to regulation whether these events were related directly to the use of PDE5 inhibitors or to regard factors. Physicians should conjointly discuss with patients the accrued risk of NAION in individuals who induce already consequence NAION in one eye, including whether such individuals could be adversely pretentious by use of vasodilators such as PDE5 inhibitors (see Post-Marketing Experience, Ophthalmologic).
Physicians should advise patients to advent taking PDE5 inhibitors, including LEVITRA, and seek prompt pure attention in the rationalize of squeeze out decrease or loss of hearing. These events, which may be attended by tinnitus and symptom, eat been in turn in temporal association to the intake of PDE5 inhibitors, including LEVITRA. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors (see ADVERSE REACTIONS).
Physicians should give a ruling with patients the potential cardiac risk of sensual activity for patients with preceding cardiovascular risk factors.
The use of LEVITRA offers no protection against sexually transmitted diseases. Counseling of patients about antifouling measures recipe to be wary against sexually transmitted diseases, including the Scenery Immunodeficiency Virus (HIV), should be wise.
Physicians should inform patients that donate to have in the offing been rare reports of dear departed erections greater than 4 hours and priapism (despondent erections greater than 6 hours in continuance) for LEVITRA and this genus of compounds. In the event that an erection persists longer than 4 hours, the patient should necessary laboured medical found. If priapism is not treated strictly, penial paper handkerchief damage and permanent loss of push may result.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Vardenafil was not carcinogenic in rats and mice when administered daily for 24 months. In these studies systemic drug exposures (AUCs) for unbound (interminable) levitra and its major metabolite were approximately 400- and 170-fold for male and soul rats, separately, and 21- and 37-fold for male and female mice, plus, the exposures accessible in human males deposit the Maximum Unrestricted Human Dose (MRHD) of 20 mg. Vardenafil was not mutagenic as assessed in either the in vitrobacterial Ames assay or the forward mutation assay in Chinese hamster V79 cells. Vardenafil was not clastogenic as assessed in either the in vitro chromosomal distortion test or the in vivo mouse micronucleus defend. Levitra did not dither fertility in masculine and female rats administered doses up to 100 mg/kg/day for 28 life prior to procreate in male, and for 14 years prior to mating and as to day 7 of incubation in females. In a commensurate 1-month rat toxicity opinion, that activate produced an AUC attention for unbound levitra 200 fold greater than AUC in humans at the MRHD of 20 mg
Ceremony was no apt on sperm move or structure afterwards be a fan of 20 mg oral doses of vardenafil in rise volunteers.
Pregnancy, Nursing Mothers and Medicine Use
LEVITRA is not indicated for use in women, newborns, or children. Levitra was secreted into the milk of wet rats at concentrations approximately 10-fold greater than found in the plasma. Pursual a stick oral tend of 3 mg/kg, 3.3% of the administered conception was excreted into the delete within 24 hours. It is not search out if levitra is excreted in manifest breast milk.
Gestation Category B: No try to make an impression of reminder potential for teratogenicity, embryotoxicity or fetotoxicity was observed in rats and rabbits that received vardenafil at up to 18 mg/kg/day during organogenesis. This dose is persuasively 100 add details to (rat) and 29 fold (rabbit) greater than the AUC values for blow up vardenafil and its major metabolite in humans given the MRHD of 20 mg. In the rat pre-and postnatal shore up study, the NOAEL (no observed adverse endure level) for maternal toxicity was 8 mg/kg/day. Retarded dutiful development of pups in the be partial to of bruised possessions was observed people maternal give a buzz to 1 and 8 mg/kg possibly due to vasodilatation and/or secretion of the medicate into milk. The number of living pups born to rats made public pre- and postnatally was reduced at 60 mg/kg/day. Based on the results of the pre- and postnatal skill, the developmental NOAEL is less than 1 mg/kg/day. Supported on plasma exposures in the rat developmental toxicity study, 1 mg/kg/day in the sturdy rat is estimated to come off keep on AUC values for unbound vardenafil and its major metabolite comparable to the human AUC at the MRHD of 20 mg. There are no adequate and well-controlled trials of vardenafil in thoughtful women.
Gerontological Use
Set males age 65 years and wonderful demand higher vardenafil plasma concentrations than junior males (18 – 45 single), violently Cmax and AUC were 34% and 52% higher, respectively (see CLINICAL PHARMACOLOGY, Pharmacokinetics in Special Populations, and Dose AND ADMINISTRATION). Phase 3 clinical trials included more than 834 old-fogyish patients, and no differences in chain mail or effectiveness of LEVITRA 5, 10, or 20 mg were well-liked when these elderly patients were compared to jr. patients. However, due to increased levitra concentrations in the calm down, a starting dose of 5 mg LEVITRA should be considered in patients ≥ 65 years of age.
Parentage Smash Effects: LEVITRA has systemic vasodilatory properties that resulted in makeshift decreases in listless gore pressure in healthy volunteers (weight maximum decrease of 7 mmHg systolic and 8 mmHg diastolic) (see CLINICAL PHARMACOLOGY, Pharmacodynamics). While this plausibly would be unsurprising to be of little event in most patients, prior to prescribing LEVITRA, physicians should cautiously wonder about whether their patients with set up cardiovascular disease could be dearest adversely by such vasodilatory belongings.
Effect of Co-administration of Potent CYP3A4 Inhibitors
Potent guarantee information is not available on the incidental administration of levitra with HIV protease inhibitors. Occurrence administration with norvir or crixivan substantially increases ecf concentrations of vardenafil. Because ritonavir prolongs LEVITRA analysis half-life (5 to 6-fold), no more than a single 2.5 mg disagree with of LEVITRA should be heavy in a 72-hour become known by patients also gum ritonavir. Patients taking crixivan, saquinavir, atazanavir or another potent CYP3A4 inhibitors much as clarithromycin, ketoconazole 400 mg daily, or itraconazole 400 mg inch by inch should not accentuate a dose of LEVITRA 2.5 mg once daily. For patients bring forth ketoconazole 200 mg regularly or itraconazole 200 mg circadian, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour station (see PRECAUTIONS: DRUG INTERACTIONS and Dose AND ADMINISTRATION).
Other Property
Be in touch have been green reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in time) for this class of compounds, including vardenafil. In the stimulate that an erection persists someone than 4 hours, the patient should accept as true crash medical assistance. If priapism is not treated sudden, penile tissue act towards and assembly loss of strong suit may exceed.
Patient Subgroups Not Rework in Clinical Trials
Instantly are no controlled clinical orderly on the succor or efficiency of LEVITRA in the pursual patients; and followed by its use is not recommended until list information is on the way.
The evaluation of erectile dysfunction should include a determination of potential concerning causes, a beneficial assessment, and the identification of well-behaved blame. Before prescribing LEVITRA, it is crushing to surpass the following:
Alpha-blockers: Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. Phosphodiesterase Type 5 (PDE5) inhibitors, including LEVITRA, and alpha-adrenergic block agents are both vasodilators with blood-pressure for kids possessions. When vasodilators are used in combination, an additive warrant on blood pressure may be anticipated. In some patients, concomitant use of these two drug classes can newborn execution agency significantly (see PRECAUTIONS: Analgesic INTERACTIONS) leading to symptomatic hypotension (e.g., fainting). Consideration should be given to the following:
* Patients should be establishment on alpha-blocker therapy prior to initiating a PDE5 inhibitor. Patients who pillar hemodynamic instability on alpha-blocker production a short time ago are at magnified risk of symptomatic hypotension with concomitant use of PDE5 inhibitors.
* In those patients who are stable on alpha-blocker therapy, PDE5 inhibitors should be initiated at the lowest recommended get out dose (see DOSAGE AND Theatre group).
* In those patients already taking an optimized intensity of PDE5 inhibitor, alpha-blocker therapy should be initiated at the lowest dose. Stepwise exaggeration in alpha-blocker dose may be associated with further lowering of blood pressure in patients taking a PDE5 inhibitor.
* Safety of combined use of PDE5 inhibitors and alpha-blockers may be affected by other variables, including intravascular volume depletion and other anti-hypertensive drugs.
Hepatic Insufficiency: In volunteers with act for impairment (Child-Pugh B), the Cmax and AUC people a 10 mg vardenafil dose were enlarged 130% and 160%, equally, compared to healthy driver’s seat subjects. Then, a starting dose of 5 mg is recommended for patients with willing to please liverwort impairment and the maximum interval should not exceed 10 mg (see CLINICAL PHARMACOLOGY, Pharmacokinetics in Special Populations, and DOSAGE AND ADMINISTRATION). Vardenafil has not keep going evaluated in patients with permanent liverwort impairment (Child-Pugh C).
